Simon M. Helfgott

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “AB1825-HPR DECISION TO INITIATE A TUMOR NECROSIS FACTOR INHIBITOR IN RHEUMATOID ARTHRITIS UNCOUPLED FROM DISEASE ACTIVITY MEASURES”.

AB1825-HPR DECISION TO INITIATE A TUMOR NECROSIS FACTOR INHIBITOR IN RHEUMATOID ARTHRITIS UNCOUPLED FROM DISEASE ACTIVITY MEASURES

(2023)10.1136/annrheumdis-2023-eular.641

N/A

0DataRank · unranked

0 citations

Christopher Adams, Anna E. Frick, Simon M. Helfgott, K. Huston, Scott Milligan +3 more

Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and “decentralized” clinical recruitment design

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108000

N/A

0DataRank · unranked

0 citations

Mary Jeffway, Thany Seyok, Harrison G. Zhang, Elena Myasoedova, John M. Davis +13 more